referat.am kursayinner referatner diplomayinner tezer պատվիրել աշխատանքներ description_1 <ol> <li>Зейдлиц А.А. Наров Ю.Э. Особенности содержания цитокинов в сыворотке крови у пациентов при раке легкого. Выпуск № 6 / 2013,с.23-29</li> <li>Злокачественные новообразования в СССР (1989-1990гг.) под редакцией Н.Н. Трапезникова, В.В. Двойрина-М ; 1991, 192с.</li> <li>Кадагидзе З.Г., Славина Е.Г., Черткова А.И. и др. Иммунологические аспекты использования цитокинов в онкологии. // Медицинская иммунология, 2001. Т. 3. - № 2. - С. 269.</li> <li>Переводчикова Н.И. Химиотерапия злокачественных опухолей. М. Медицина,2012с</li> <li>Bhattacharya, Biplob, and Sreya Mukherjee. &quot;Cancer Therapy Using Antibiotics.&quot;&nbsp;<em>Journal of Cancer Therapy</em>&nbsp;6.10 (2015): 849.</li> <li>Cancer Research Review. An Overview of Recent Cancer Research Publications Featuring Illumina&reg; Technology (<a href="https://www.illumina.com/content/dam/illumina-marketing/documents/products/research_reviews/cancer_research_review.pdf">https://www.illumina.com/content/dam/illumina-marketing/documents/products/research_reviews/cancer_research_review.pdf</a>)</li> <li>Vincent T.,&nbsp;DeVita&nbsp;Jr.&nbsp;and&nbsp;Edward&nbsp;Chu, A History of Cancer Chemotherapy, Cancer research,<br /> 68 (21), 2008</li> <li>Rieffel, J., Chen, F., Kim, J., Chen, G., Shao, W., Shao, S., Chitgupi, U., Hernandez, R., Graves, S.A., Nickles, R.J. and Prasad, P.N., 2015. Hexamodal Imaging with Porphyrin‐Phospholipid‐Coated Upconversion Nanoparticles.&nbsp;Advanced Materials,&nbsp;27(10), pp.1785-1790.</li> <li>Tacar, O., Sriamornsak, P. and Dass, C.R. (2013) Doxorubicin: An Update on Anticancer Molecular Action, Toxicity and Novel Drug Delivery Systems. Journal of Pharmacy and Pharmacology, 65, 157-170.</li> <li>Brockmann, H. (1963) Anthracyclinones and Anthracyclines. (Rhodomycinone, Pyrromycinone and Their Glycosides). Fortschritte der Chemie organischer Naturstoffe, 21, 121-182.</li> <li>Zunino, F. and Capranico, G. (1990) DNA Topoisomerase II as the Primary Target of Anti-Tumor Anthracyclines. Anti-Cancer Drug Design, 5, 307-317.</li> <li>Arcamone, F. (1985) Properties of Antitumor Anthracyclines and New Developments in Their Application: Cain Memorial Award Lecture. Cancer Research, 45, 5995-5999.</li> <li>Cortes-Funes, H. and Coronado, C. (2007) Role of Anthracyclines in the Era of Targeted Therapy. Cardiovascular Toxicology, 7, 56-60.</li> <li>Arcamone, F., Cassinelli, G., Fantini, G., Grein, A., Orezzi, P., Pol, C. and Spalla, C. (1969) Adriamycin, 14-Hydroxydaunomycin, a New Antitumor Antibiotic from S. peucetius var. caesius. Biotechnology and Bioengineering, 11, 1101-1110.</li> <li>Moore, S., Patel, R.P., Atherton, E., Kondo, M., Meienhofer, J. (1976) Synthesis and Some Properties and Antitumor Effects of the Actinomycin Lactam Analog, (Di(1-L-Alpha, Beta-Diaminopropionic))Actinomycin D1. Journal of Medicinal Chemistry, 19, 766-772.</li> </ol> <p>&nbsp;</p> description_2 <p>ՆԵՐԱԾՈՒԹՅՈՒՆ</p> <p>ՔԱՂՑԿԵՂ ԵՎ ԴԵՂՈՐԱՅՔԱՅԻՆ ԲՈՒԺՈՒՄ</p> <p>ՀԱԿԱՈՒՌՈՒՑՔԱՅԻՆ&nbsp;ՀԱԿԱԲԻՈՏԻԿՆԵՐ&nbsp;</p> <p>ԵԶՐԱԿԱՑՈՒԹՅՈՒՆ</p> <p>&nbsp;ԳՐԱԿԱՆՈՒԹՅԱՆ ՑԱՆԿ</p> title_arm Հակաուռուցքային հակաբիոտիկներ title_eng convertot_1 Hakaurucqayin hakabiotikner convertot_2 Hakaurucqayin hakabiotikner convertot_3 Hakaurucqayin hakabiotikner convertot_4 Hakaurucqayin hakabiotikner convertot_5 Hakaurucqayin hakabiotikner convertot_6 Hakaurucqayin hakabiotikner convertot_7 Hakaurucqayin hakabiotikner convertot_8 Hakaurucqayin hakabiotikner convertot_9 Hakaurucqayin hakabiotikner convertot_10 Hakaurucqayin hakabiotikner convertot_11 Hakaurucqayin hakabiotikner convertot_13 Hakaurucqajin hakabiotikner convertot_14 Hakaurucqayin hakabiwtikner convertot_15 Hakaurucqayin hakabiotikner convertot_16 Hakayrycqayin hakabiotikner convertot_17 Hakauruckayin hakabiotikner convertot_18 Hakaurucqayin hakabiotikner